Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05261633 · ClinicalTrials.gov registry record
Diffusion MRI of the Abdomen
A clinical trial of Abdominal Imaging, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT05261633: Recruiting study of Abdominal Imaging, sponsored by University of Wisconsin, Madison.
NCT05261633 is a study of Abdominal Imaging that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05261633, a study of Abdominal Imaging, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to see if a new magnetic resonance imaging (MRI) method will be able to improve the images taken of the abdomen. This new method includes some changes to help avoid movements that may disrupt the images like breathing, heartbeats and other involuntary motion that occurs in the abdomen. This study will these methods in healthy volunteers and validate them in patients with known liver metastases in a single contrast-enhanced MRI visit.
Primary Outcome
Compare the repeatability of DW-MRI methods by calculating the squared difference between each pair of repeated apparent diffusion coefficient (ADC) measurements in lesions and healthy tissue, and will model this value including the DW-MRI method as a covariate using Generalized Estimating Equations (GEE).
Conditions Studied
Interventions
- DEVICE Diffusion Weighted Magnetic Resonance Imaging
Study Locations (1)
Wisconsin
- University of Wisconsin School of Medicine and Public Health - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-11-22 |
| Est. Completion | 2026-06-30 |
What NCT05261633 shows while recruiting
NCT05261633 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 1 condition, with Abdominal Imaging appearing as the primary indexed condition, and to 1 intervention - of which Diffusion Weighted Magnetic Resonance Imaging is the first listed.
NCT05261633 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05261633 about?
NCT05261633 is a clinical study titled "Diffusion MRI of the Abdomen". The purpose of this research is to see if a new magnetic resonance imaging (MRI) method will be able to improve the images taken of the abdomen. This new method includes some changes to help avoid movements that may disrupt the images like breathing, heartbeats and other involuntary motion that occu...
What is the current status of trial NCT05261633?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2023-11-22. Estimated completion is 2026-06-30.
What conditions does trial NCT05261633 study?
This clinical trial studies the following conditions: Abdominal Imaging.
What interventions are being tested in trial NCT05261633?
The interventions under investigation include: Diffusion Weighted Magnetic Resonance Imaging (DEVICE).
Who is sponsoring clinical trial NCT05261633?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05261633 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI